ArticleNature communications2026
Weakly supervised artificial intelligence for multi-cancer detection of lymph node metastasis on whole slide images.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Weakly supervised artificial intelligence for multi-cancer detection of lymph node metastasis on whole slide images.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The accurate identification of lymph node metastasis is critical for cancer diagnosis/treatment but remains time-consuming and error-prone for pathologists. We develop MambaMIL+HiLA-MIL, a multiple instance learning model combining Vision Mamba with high-low attention separation mechanism. This model is compared against six baselines under four feature extractors (ResNet, UNI, Virchow, and GigaPath). Ten-fold cross-validation is employed for model evaluation. Our model significantly outperforms all baselines. It exhibits strong performance in detection of isolated tumor cells and micro-metastasis, while maintaining high performance for negative and macro-metastasis cases. The model still demonstrates good stability in detecting lymph node metastasis across multi-cancer and various individual cancer types. UNI and GigaPath yield significantly better performance than ResNet and Virchow. Here, we show that MambaMIL+HiLA-MIL is a multi-cancer four-class lymph node metastasis model, demonstrating high efficiency and robustness across multiple centers and various feature extractors, offering a reliable tool for clinical lymph node metastasis classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.